BDBM50195402 CHEMBL374329::N-(4-(benzo[d][1,3]dioxol-5-yl)benzyl)-N-(2-(dibutylamino)ethyl)-4-pentylbenzamide
SMILES: CCCCCc1ccc(cc1)C(=O)N(CCN(CCCC)CCCC)Cc1ccc(cc1)-c1ccc2OCOc2c1
InChI Key: InChIKey=JVCORHZVEQMEQL-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Plasmepsin 2 (Plasmodium falciparum) | BDBM50195402 (CHEMBL374329 | N-(4-(benzo[d][1,3]dioxol-5-yl)benz...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 101 | n/a | n/a | n/a | n/a | n/a | n/a |
Actelion Pharmaceuticals Ltd Curated by ChEMBL | Assay Description Inhibition of PM2 by FRET assay | Bioorg Med Chem Lett 16: 6194-9 (2006) Article DOI: 10.1016/j.bmcl.2006.09.027 BindingDB Entry DOI: 10.7270/Q2QJ7GZN | |||||||||||
More data for this Ligand-Target Pair |